Artivion (AORT) Q4 Earnings Outlook: Revenue Up 20.2% Y/Y, EPS $0.18

Artivion (NYSE:AORT) reports fourth-quarter results on Friday, February 14, 2026. Last quarter, the medical device company earned $113.4 million in revenue, 18.4% higher than the prior-year period and 2.6% above analyst expectations. For Q4, revenue is forecast to rise 20.2% year on year to $117 million, with adjusted earnings per share expected at $0.18. Analysts have averaged their estimates over the past 30 days, and the company has beaten revenue expectations in 22 of 24 quarters since 2024, with a 2.4% average outperformance. Peer performance is mixed: Envista (+17.8%) outpaced guidance, while Neogen (-2.8%) exceeded estimates despite a revenue decline. Artivion is down 4.1% over the past month versus a -3.7% average for healthcare equipment and supplies stocks; its average analyst price target is $51.71, compared to a current share price of $40.94.